[HTML][HTML] A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming

DM Lyra-Leite, Ó Gutiérrez-Gutiérrez, M Wang, Y Zhou… - STAR protocols, 2022 - Elsevier
The methods for the culture and cardiomyocyte differentiation of human embryonic stem
cells, and later human induced pluripotent stem cells (hiPSC), have moved from a complex …

An autonomously swimming biohybrid fish designed with human cardiac biophysics

KY Lee, SJ Park, DG Matthews, SL Kim, CA Marquez… - Science, 2022 - science.org
Biohybrid systems have been developed to better understand the design principles and
coordination mechanisms of biological systems. We consider whether two functional …

Molecular mechanisms underlying pluripotency and self-renewal of embryonic stem cells

F Varzideh, J Gambardella, U Kansakar… - International Journal of …, 2023 - mdpi.com
Embryonic stem cells (ESCs) are derived from the inner cell mass (ICM) of the blastocyst.
ESCs have two distinctive properties: ability to proliferate indefinitely, a feature referred as …

Cadherin‐5 facilitated the differentiation of human induced pluripotent stem cells into sinoatrial node‐like pacemaker cells by regulating β‐catenin

W Zhang, F Wang, L Yin, Y Tang… - Journal of Cellular …, 2024 - Wiley Online Library
Our study was conducted to investigate whether cadherin‐5 (CDH5), a vascular endothelial
cell adhesion glycoprotein, could facilitate the differentiation of human induced pluripotent …

[HTML][HTML] The sinoatrial node extracellular matrix promotes pacemaker phenotype and protects automaticity in engineered heart tissues from cyclic strain

YH Sun, HKJ Kao, PN Thai, R Smithers, CW Chang… - Cell reports, 2023 - cell.com
The composite material-like extracellular matrix (ECM) in the sinoatrial node (SAN) supports
the native pacemaking cardiomyocytes (PCMs). To test the roles of SAN ECM in the PCM …

A new paradigm for generating high-quality cardiac pacemaker cells from mouse pluripotent stem cells

Z Lin, B Lin, C Hang, R Lu, H Xiong, J Liu… - … and Targeted Therapy, 2024 - nature.com
Cardiac biological pacing (BP) is one of the future directions for bradyarrhythmias
intervention. Currently, cardiac pacemaker cells (PCs) used for cardiac BP are mainly …

Nanomaterials modulating stem cell behavior towards cardiovascular cell lineage

H Arzaghi, B Rahimi, B Adel, G Rahimi, Z Taherian… - Materials …, 2021 - pubs.rsc.org
The cardiovascular system is one of the most complex and indispensable systems in the
body and is responsible for the circulation of nutrition, oxygen, carbon dioxide, hormones to …

Decoding genetics of congenital heart disease using patient-derived induced pluripotent stem cells (iPSCs)

H Lin, KL McBride, V Garg, MT Zhao - Frontiers in Cell and …, 2021 - frontiersin.org
Congenital heart disease (CHD) is the most common cause of infant death associated with
birth defects. Recent next-generation genome sequencing has uncovered novel genetic …

Subtype-specific cardiomyocytes for precision medicine: Where are we now?

MT Zhao, NY Shao, V Garg - Stem Cells, 2020 - academic.oup.com
Patient-derived pluripotent stem cells (PSCs) have greatly transformed the current
understanding of human heart development and cardiovascular disease. Cardiomyocytes …

[HTML][HTML] NODAL inhibition promotes differentiation of pacemaker-like cardiomyocytes from human induced pluripotent stem cells

S Yechikov, HKJ Kao, CW Chang, D Pretto, XD Zhang… - Stem cell …, 2020 - Elsevier
Directed cardiomyogenesis from human induced pluripotent stem cells (hiPSCs) has been
greatly improved in the last decade but directed differentiation to pacemaking …